Effect of Intravenous Scopolamine Before Stapling on Postoperative Nausea and Vomiting in Sleeve Gastrectomy Patients

Determining the Effect of Intravenous Scopolamine Before the Stapling Stage on Postoperative Nausea and Vomiting in Sleeve Gastrectomy Patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N75

Enrollment

100

Registered

2026-05-10

Start date

2026-06-04

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group: This group will serve as the intervention group, and 20 mg of intravenous scopolamine will be administered by the anesthesiologist before placement of the first sta

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Class III obesity (body mass index greater than 40 kg/m²) Candidates for sleeve gastrectomy surgery

Exclusion criteria

Exclusion criteria: History of uncontrolled hypertension History of kidney disease

Design outcomes

Primary

Measure	Time frame
Nausea and vomiting. Timepoint: Every hour during the first 24 hours after surgery. Method of measurement: Occurrence of nausea and vomiting.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026